DLEU2 and clear cell renal carcinoma: Moreover, lncRNA DLEU2 was not only involved in NSCLC, but also in clear cell renal cell carcinoma [22] and chronic lymphocytic leukemia [14], which indicated that lncRNA DLEU2 may act as a biomarker for clinical diagnosis of NSCLC.